AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.9113
+0.0194 (2.18%)
At close: Jun 13, 2025, 4:00 PM
0.9113
0.00 (0.00%)
Pre-market: Jun 16, 2025, 5:58 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $10.30 million as of June 16, 2025. Its market cap has decreased by -80.92% in one year.
Market Cap
10.30M
Enterprise Value
14.46M
1-Year Change
-80.92%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $10.30M, a decrease of -83.82%. That is a compound annual growth rate of -35.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 10.30M | -52.27% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |